These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26186905)

  • 21. ACTH: The forgotten therapy.
    Montero-Melendez T
    Semin Immunol; 2015 May; 27(3):216-26. PubMed ID: 25726511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities.
    Surh YJ
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():269-72. PubMed ID: 18296353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents.
    Gaba M; Singh S; Mohan C
    Eur J Med Chem; 2014 Apr; 76():494-505. PubMed ID: 24602792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.
    Brzoska T; Böhm M; Lügering A; Loser K; Luger TA
    Adv Exp Med Biol; 2010; 681():107-16. PubMed ID: 21222263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory prostanoids: focus on the interactions between electrophile signaling and resolution of inflammation.
    Díez-Dacal B; Pérez-Sala D
    ScientificWorldJournal; 2010 Apr; 10():655-75. PubMed ID: 20419278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological opportunities to control inflammatory diseases through inhibition of the leukocyte recruitment.
    Peres RS; Menezes GB; Teixeira MM; Cunha FQ
    Pharmacol Res; 2016 Oct; 112():37-48. PubMed ID: 26808082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies.
    Harris SJ; Foster JG; Ward SG
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1151-62. PubMed ID: 19876783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of natural product characterization in studies of their anti-inflammatory activity.
    Gosslau A; Li S; Ho CT; Chen KY; Rawson NE
    Mol Nutr Food Res; 2011 Jan; 55(1):74-82. PubMed ID: 21207514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory targets of therapy in sickle cell disease.
    Owusu-Ansah A; Ihunnah CA; Walker AL; Ofori-Acquah SF
    Transl Res; 2016 Jan; 167(1):281-97. PubMed ID: 26226206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of inflammasome blockers as anti-inflammatory drugs.
    López-Castejón G; Pelegrín P
    Expert Opin Investig Drugs; 2012 Jul; 21(7):995-1007. PubMed ID: 22612568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of inflammation: a new therapeutic frontier.
    Fullerton JN; Gilroy DW
    Nat Rev Drug Discov; 2016 Aug; 15(8):551-67. PubMed ID: 27020098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemokines a hope of specific anti-inflammatory treatment].
    Schedvins P; Hjelmström P
    Lakartidningen; 2002 Mar; 99(10):1056-9. PubMed ID: 12024779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Catenin-mediated signaling: a novel molecular target for chemoprevention with anti-inflammatory substances.
    Kundu JK; Choi KY; Surh YJ
    Biochim Biophys Acta; 2006 Jan; 1765(1):14-24. PubMed ID: 16226380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular signaling modifications involved in the anti-inflammatory effect of 4-alkoxy-6,9-dichloro[1,2,4]triazolo[4,3-a]quinoxalines on macrophages.
    Ruiz-Alcaraz AJ; Tristán-Manzano M; Guirado A; Gálvez J; Martínez-Esparza M; García-Peñarrubia P
    Eur J Pharm Sci; 2017 Mar; 99():292-298. PubMed ID: 28057547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
    Kim J; Kim H; Park SB
    J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
    Goulding NJ
    Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What makes a good anti-inflammatory drug target?
    Simmons DL
    Drug Discov Today; 2006 Mar; 11(5-6):210-9. PubMed ID: 16580598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
    Nunes AK; Rapôso C; Rocha SW; Barbosa KP; Luna RL; da Cruz-Höfling MA; Peixoto CA
    Brain Res; 2015 Nov; 1627():119-33. PubMed ID: 26404052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid molecules: The privileged scaffolds for various pharmaceuticals.
    Shaveta ; Mishra S; Singh P
    Eur J Med Chem; 2016 Nov; 124():500-536. PubMed ID: 27598238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.